93 related articles for article (PubMed ID: 15184351)
1. Simvastatin combined with ramipril treatment in hypercholesterolemic patients.
Koh KK; Son JW; Ahn JY; Kim DS; Jin DK; Kim HS; Han SH; Seo YH; Chung WJ; Kang WC; Shin EK
Hypertension; 2004 Aug; 44(2):180-5. PubMed ID: 15184351
[TBL] [Abstract][Full Text] [Related]
2. Vascular effects of simvastatin combined with ramipril in hypercholesterolemic patients with coronary artery disease, compared with simvastatin alone: a randomized, double-blind, placebo-controlled, crossover study.
Koh KK; Son JW; Ahn JY; Jin DK; Kim HS; Kim DS; Han SH; Chung WJ; Park GS; Shin EK
Atherosclerosis; 2004 Nov; 177(1):147-53. PubMed ID: 15488877
[TBL] [Abstract][Full Text] [Related]
3. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.
Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Seo YH; Kang MH; Ahn TH; Choi IS; Shin EK
Circulation; 2004 Dec; 110(24):3687-92. PubMed ID: 15569835
[TBL] [Abstract][Full Text] [Related]
4. Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes.
Koh KK; Quon MJ; Han SH; Ahn JY; Jin DK; Kim HS; Kim DS; Shin EK
Hypertension; 2005 Jun; 45(6):1088-93. PubMed ID: 15883229
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.
Abdel-Zaher AO; Elkoussi AE; Abudahab LH; Elbakry MH; Elsayed EA
Fundam Clin Pharmacol; 2012 Dec; 26(6):701-11. PubMed ID: 21913974
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes.
Koh KK; Quon MJ; Han SH; Ahn JY; Lee Y; Shin EK
Atherosclerosis; 2007 Sep; 194(1):230-7. PubMed ID: 16965776
[TBL] [Abstract][Full Text] [Related]
7. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients.
Han SH; Koh KK; Quon MJ; Lee Y; Shin EK
Atherosclerosis; 2007 Jan; 190(1):205-11. PubMed ID: 16500662
[TBL] [Abstract][Full Text] [Related]
8. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women.
Koh KK; Cardillo C; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
Circulation; 1999 Jan; 99(3):354-60. PubMed ID: 9918521
[TBL] [Abstract][Full Text] [Related]
9. Vascular effects of diet and statin in hypercholesterolemic patients.
Koh KK; Son JW; Ahn JY; Jin DK; Kim HS; Choi YM; Ahn TH; Kim DS; Shin EK
Int J Cardiol; 2004 Jun; 95(2-3):185-91. PubMed ID: 15193818
[TBL] [Abstract][Full Text] [Related]
10. Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein.
Abdel-Zaher AO; Elkoussi AE; Abudahab LH; Elbakry MH; Elsayed EA
Fundam Clin Pharmacol; 2014 Jun; 28(3):237-48. PubMed ID: 23488690
[TBL] [Abstract][Full Text] [Related]
11. Effect of statin therapy added to ACE-inhibitors on blood pressure control and endothelial functions in normolipidemic hypertensive patients.
Danaoğlu Z; Kültürsay H; Kayikçioğlu M; Can L; Payzin S
Anadolu Kardiyol Derg; 2003 Dec; 3(4):331-7. PubMed ID: 14675884
[TBL] [Abstract][Full Text] [Related]
12. Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet.
Koh KK; Son JW; Ahn JY; Choi YM; Jin DK; Park GS; Choi IS; Sohn MS; Shin EK
Coron Artery Dis; 2001 Jun; 12(4):305-11. PubMed ID: 11428539
[TBL] [Abstract][Full Text] [Related]
13. Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study.
Hamoud S; Hayek T; Volkova N; Attias J; Moscoviz D; Rosenblat M; Aviram M
Atherosclerosis; 2014 Jan; 232(1):204-10. PubMed ID: 24401239
[TBL] [Abstract][Full Text] [Related]
14. Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins.
Geiss HC; Otto C; Hund-Wissner E; Parhofer KG
Atherosclerosis; 2005 May; 180(1):107-12. PubMed ID: 15823282
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent responses in patients with hypercholesterolemic coronary artery disease under the effects of simvastatin and enalapril, either separately or combined.
Esper RJ; Machado R; Vilariño J; Cacharrón JL; Ingino CA; García Guiñazú CA; Bereziuk E; Bolaño AL; Suarez DH
Am Heart J; 2000 Oct; 140(4):684-9. PubMed ID: 11011346
[TBL] [Abstract][Full Text] [Related]
17. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.
Clarkson P; Adams MR; Powe AJ; Donald AE; McCredie R; Robinson J; McCarthy SN; Keech A; Celermajer DS; Deanfield JE
J Clin Invest; 1996 Apr; 97(8):1989-94. PubMed ID: 8621785
[TBL] [Abstract][Full Text] [Related]
18. The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia.
Stein JH; Carlsson CM; Papcke-Benson K; Aeschlimann SE; Bodemer A; Carnes M; McBride PE
J Am Coll Cardiol; 2001 Dec; 38(7):1806-13. PubMed ID: 11738278
[TBL] [Abstract][Full Text] [Related]
19. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
Farnier M; Volpe M; Massaad R; Davies MJ; Allen C
Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505
[TBL] [Abstract][Full Text] [Related]
20. Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
Rajagopalan S; Zannad F; Radauceanu A; Glazer R; Jia Y; Prescott MF; Kariisa M; Pitt B
Am J Cardiol; 2007 Jul; 100(2):222-6. PubMed ID: 17631074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
